Prostate cancer: diagnosis and management

You can now review and comment on this draft guideline.

The consultation closes on 16 January 2019 at 5pm

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline– just the recommendations
• Evidence reviews:
• Evidence review A - bisphosphonates
• Evidence review B - docetaxel in people with hormone sensitive prostate cancer
• Evidence review C- radical radiotherapy
• Evidence review D - diagnosing and identifying clinically significant prostate cancer
• Evidence review E - following-up people at risk of prostate cancer
• Evidence review F- identifying prostate cancer clinical progression in people with low-intermediate risk cancer
• Evidence review G - active surveillance, radical prostatectomy or radical radiotherapy in people with localised prostate cancer
• Evidence review H - follow up protocols after radical treatment
• Health economic report
• Acknowledgements
• Algorithm

If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee member list and register of interests
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: ProstateCancer@nice.org.uk

Deadline: 16 January 2019, 5pm

5. Economic model

The developer has produced an economic model to support the guideline on Prostate cancer: diagnosis and management (update). To receive an executable version of this model, please submit a request to ProstateCancer@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 16 January 2019 at 5pm.